Inarigivir|475650-36-3|(ORI-9020; SB-9000)-陌孚医药/Medlife

您当前的位置：

Inarigivir (Synonyms: ORI-9020; SB-9000)

目录号: PL01315

CAS No. :475650-36-3

商品编号	规格	价格	会员价
PL01315-5mg	5mg	¥20090.00	请登录
PL01315-10mg	10mg	询价	询价
PL01315-50mg	50mg	询价	询价

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Inarigivir
英文名称	Inarigivir
英文别名	1-[4-[[5-(6-Aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethy;ORI-9020;SB-9000;2’-O-Methyl-P-thiouridylyl-(3’→5’)-2’-deoxyadenosine;Inarigivir
Cas No.	475650-36-3
分子式	C₂₀H₂₆N₇O₁₀PS
分子量	587.50
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情

Inarigivir (ORI-9020;SB-9000) 是一种二核苷酸抗病毒化合物，可显着减少表达乙型肝炎病毒转基因小鼠的 HBV DNA。Inarigivir (ORI-9020) 是 RIG-I 的激动剂，可激活细胞内的先天免疫。

生物活性

Inarigivir (ORI-9020) is a dinucleotide antiviral drug that can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) act as a RIG-I agonist to activate cellular innate immune responses.

性状

Solid

IC50 & Target[1][2]

Target: HBV

体外研究(In Vitro)

Inarigivir (SB 9200) is active against HBV variants carrying resistance markers against all the nucleos(t)ide analogues approved for treating chronic hepatitis B. has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Inarigivir (100 mg/kg/day, ip) significantly reduces viral DNA in the liver and shows anti-HBV activity. Serum HBV DNA is not reduced in response to treatment. Inarigivir does not affect levels of HBV RNA in liver, levels of HBeAg in serum, or mean titers of HBsAg. The minimal effective dose is identified to be between 1.6 and 0.5 mg/kg/day using liver HBV DNA values. has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder -20°C 3 years；4°C 2 years

ClinicalTrial

参考文献

[1]. Iyer RP, et al. Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrob Agents Chemother. 2004 Jun;48(6):2318-20.
[2]. Danni Colledge, et al. The Novel Antiviral Agent Inarigivir Inhibits Both Nucleos(t)ide Analogue and Capsid Assembly Inhibitor Resistant HBV in vitro.

溶解度数据	In Vitro: DMSO : 200 mg/mL (340.43 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation